These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) study. Fox K; Ferrari R; Tendera M; Steg PG; Ford I; Am Heart J; 2006 Nov; 152(5):860-6. PubMed ID: 17070146 [TBL] [Abstract][Full Text] [Related]
3. Focus on ivabradine: a new heart rate-controlling drug. Riccioni G Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):107-13. PubMed ID: 19210206 [TBL] [Abstract][Full Text] [Related]
4. Long-term safety and efficacy of ivabradine in patients with chronic stable angina. López-Bescós L; Filipova S; Martos R Cardiology; 2007; 108(4):387-96. PubMed ID: 17890862 [TBL] [Abstract][Full Text] [Related]
6. The Role of Ivabradine in the Management of Angina Pectoris. Giavarini A; de Silva R Cardiovasc Drugs Ther; 2016 Aug; 30(4):407-417. PubMed ID: 27475447 [TBL] [Abstract][Full Text] [Related]
7. Efficacy Profile of Ivabradine in Patients with Heart Failure plus Angina Pectoris. Borer JS; Swedberg K; Komajda M; Ford I; Tavazzi L; Böhm M; Depre C; Wu Y; Maya J; Dominjon F Cardiology; 2017; 136(2):138-144. PubMed ID: 27614723 [TBL] [Abstract][Full Text] [Related]
8. [Ivabradine -- a novel approach for heart rate lowering]. Er F; Hoppe UC Dtsch Med Wochenschr; 2005 Jun; 130(24):1501-2. PubMed ID: 15942839 [No Abstract] [Full Text] [Related]
9. [Angina pectoris: improving symptoms and prognosis. With ivabradine less angina pectoris and reduced need for nitrates]. MMW Fortschr Med; 2011 Jun; 153(24-25):56-7. PubMed ID: 21717715 [No Abstract] [Full Text] [Related]
10. [Stable angina pectoris. Effective symptom control and cardioprotection with ivabradine]. MMW Fortschr Med; 2010 May; 152(21):102-3. PubMed ID: 20608138 [No Abstract] [Full Text] [Related]
11. Selective and specific I(f) inhibition: new perspectives for the treatment of stable angina. Fox K Expert Opin Pharmacother; 2006 Jun; 7(9):1211-20. PubMed ID: 16732707 [TBL] [Abstract][Full Text] [Related]
12. Quality of Life With Ivabradine in Patients With Angina Pectoris: The Study Assessing the Morbidity-Mortality Benefits of the If Inhibitor Ivabradine in Patients With Coronary Artery Disease Quality of Life Substudy. Tendera M; Chassany O; Ferrari R; Ford I; Steg PG; Tardif JC; Fox K; Circ Cardiovasc Qual Outcomes; 2016 Jan; 9(1):31-8. PubMed ID: 26696613 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of I(f) inhibition with ivabradine in different subpopulations with stable angina pectoris. Tendera M; Borer JS; Tardif JC Cardiology; 2009; 114(2):116-25. PubMed ID: 19468225 [TBL] [Abstract][Full Text] [Related]
15. Ivabradine for stable angina? Drug Ther Bull; 2008 Nov; 46(11):84-8. PubMed ID: 18987382 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of unstable angina with diltiazem. A propos of 61 observations]. Nicolas G; Godin JF; Laplanche P Ann Cardiol Angeiol (Paris); 1981; 30(4):289-92. PubMed ID: 6976148 [No Abstract] [Full Text] [Related]
18. A new combination therapy in stable angina pectoris. Sajadieh A Eur Heart J; 2009 Mar; 30(5):524-5. PubMed ID: 19193673 [No Abstract] [Full Text] [Related]
19. Treatment of stable angina pectoris by ivabradine in every day practice: the REDUCTION study. Köster R; Kaehler J; Meinertz T; Am Heart J; 2009 Oct; 158(4):e51-7. PubMed ID: 19781403 [TBL] [Abstract][Full Text] [Related]
20. [From results of BEAUTIFUL trial to results of SHIFT trial: BEAUTIFUL possibility to make a SHIFT in current guidelines]. Lopatin IuM Kardiologiia; 2011; 51(5):85-90. PubMed ID: 21649600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]